| • | Distribution Europe - Funding |
 |
 |
A-Medica. Meditech Strategic Consultants partners with A-Medica for activities like distribution and funding of niche medical technologies and devicess across European markets. See www.a-medica.com.
| • | EU / US CRO - EU Reimbursement |
QUINTILES
The regulation of pricing and reimbursement of medical devices shows significant variation throughout the European markets. With an increasing number of formal reimbursement processes, budgetary restrictions, growing competition and introduction of DRG-like systems across Europe, successful and quick market access is an increasing challenge. To obtain the best price and to get your product reimbursed it is essential to take into account all variables that will influence these two processes.
With extensive experience in numerous countries around the globe and our network of experienced country staff, our assistance includes:
Ř Performing an assessment of the roles of national, regional and hospital decision makers in the reimbursement and pricing processes with regards to your product;
Ř Elucidating current and planned budget constraints, pricing history and likely future changes in the pricing processes relevant to your product;
Ř Clarifying the decision making process for determining a reimbursement level and setting a price for your product, identifying the key arguments to be made to achieve a premium price, and finding the key influencers. We have experience with both hospital and non-hospital products;
Ř Determining the influence of health economic arguments, including budget impact analyses on pricing, reimbursement and formulary inclusion decisions;
Ř Recommendations of outcome studies which could be carried out in the timeframe available if they are key to support reimbursement, pricing and formulary listing applications;
Ř Writing reimbursement dossiers in officially required formats and submitting them to the relevant authorities;
Ř Support in pricing negotiations with the healthcare authorities and major payers;
Ř Constructing dossiers to support formulary inclusion, and assistance in presenting them to key decision makers.
| • | Distributor Ophthalmology Products |
M.C.I.
Although graduated as an optometrist in 1984, Guy van de Weyer has spent over twenty years in the field of ophthalmic surgery and lasers. He assisted in the development and introduction of various innovative surgical techniques, such as phaco-emulsification, laser thermal keratoplasty and conductive keratoplasty. He has given lectures, instructional courses and workshops at multiple universities, surgery centers, international courses and meetings worldwide. He is athor or co-author of several publications on phaco- emulsification and keratoplasty technology. Operating as an independent consultant, he has worked with numerous American, European and Japanese manufacturing companies. Born and living in Flanders (Belgium), his operational area covers Europe, Africa and the Middle East. Being fluent in multiple languages and always open for new cultural experiences, he has established life long relationships in all continents of the world.
M.C.I. bvba
Hofstraat 56
9140 - Tielrode
Belgium
Tel. +32.3.765.05.55
Fax. +32.3.765.05.56
e-mail: gvdw@mci.be
| • | Support in manufacturing facilities/logistics - Funding |
LIOF
Industriebank LIOF is a public/private organization , providing services to assist new business entries for Limburg, ranging from setting up meetings with key companies and/or organizations and providing tailor-made guidance and assistance to identify (office or manufacturing) facilities, logistics, subsidy (grant) arrangements for product development and settling in Limburg.
LIOF has been, and is instrumental in landing such companies in Limburg. LIOF provides support and advisory services and has proven to be successful in this. Numerous EU and OEU companies have settled in the region.
| • | Australian CRO - Pacific Clinical Research Group |
Pacific Clinical Research Group (PCRG), an Australian owned contract research organization offering services to companies, institutions and individuals wishing to perform clinical trials in Australia, New Zealand and Asia. Their staff has a combined experience in the conduct of over 200 successful clinical trials ranging from small first-in-man studies through to large multi-center global trials.
Historically, PCRG focused primarily on early stage trials of new medical devices and drugs for cardiac and vascular disease. However, the team now has the expertise and capacity to provide clinical trial solutions in all therapeutic arenas.
They have staff and affiliates not only throughout the Asia-Pacific region but also strategic partners in the United States. By utilizing our significant resources in these various geographies we are able to offer a personalized, tailored service to meet all of your clinical trial needs.
Website PCRG: www.pcrg.com.au